{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:49:18Z","timestamp":1791920958483,"version":"4.3.4"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:00:00Z","timestamp":1791417600000},"content-version":"vor","delay-in-days":7,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007277","name":"Icahn School of Medicine at Mount Sinai","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007277","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["biologicalpsychiatryjournal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biological Psychiatry"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.biopsych.2026.10.004","type":"journal-article","created":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T06:15:25Z","timestamp":1791785725000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Development of a messenger RNA therapy for schizophrenia"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3952-1458","authenticated-orcid":false,"given":"Nicole W.","family":"Simons","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-9918-9394","authenticated-orcid":false,"given":"Vibhuti","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoyuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4351-9975","authenticated-orcid":false,"given":"Shruti","family":"Iyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yichen","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinglingge","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changyue","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Obiajulu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4651-3413","authenticated-orcid":false,"given":"Katherine","family":"Keller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gavin","family":"Hynes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajiv","family":"Nadukuru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Earnest P.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Hashemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anina N.","family":"Lund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry C.","family":"Rogers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5266-8465","authenticated-orcid":false,"given":"Michael","family":"Preuss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Thibeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Girish N.","family":"Nadkarni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lora E.","family":"Liharska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis S.","family":"Charney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mafalda","family":"Barbosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuele G.","family":"Marro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren\u00e9 S.","family":"Kahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yizhou","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8135-6858","authenticated-orcid":false,"given":"Alexander W.","family":"Charney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.biopsych.2026.10.004_bib1","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1007\/s40265-023-01882-9","article-title":"Targeting IL-23 for IBD: Rationale and Progress to Date","volume":"83","author":"Vuyyuru","year":"2023","journal-title":"Drugs"},{"issue":"8","key":"10.1016\/j.biopsych.2026.10.004_bib2","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa2004215","article-title":"Evinacumab for Homozygous Familial Hypercholesterolemia","volume":"383","author":"Raal","year":"2020","journal-title":"N Engl J Med"},{"issue":"363","key":"10.1016\/j.biopsych.2026.10.004_bib3","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aag1974","article-title":"Resolving TYK2 locus genotype-to-phenotype differences in autoimmunity","volume":"8","author":"Dendrou","year":"2016","journal-title":"Sci Transl Med"},{"issue":"1","key":"10.1016\/j.biopsych.2026.10.004_bib4","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1056\/NEJMoa1307095","article-title":"Loss-of-function mutations in APOC3, triglycerides, and coronary disease","volume":"371","author":"Blood","year":"2014","journal-title":"N Engl J Med"},{"issue":"23","key":"10.1016\/j.biopsych.2026.10.004_bib5","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1056\/NEJMoa1400284","article-title":"Targeting APOC3 in the familial chylomicronemia syndrome","volume":"371","author":"Gaudet","year":"2014","journal-title":"N Engl J Med"},{"issue":"23","key":"10.1016\/j.biopsych.2026.10.004_bib6","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1056\/NEJMoa1002926","article-title":"Exome sequencing, ANGPTL3 mutations, and familial combined hypolipidemia","volume":"363","author":"Musunuru","year":"2010","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.biopsych.2026.10.004_bib7","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/nrd.2016.230","article-title":"A comprehensive map of molecular drug targets","volume":"16","author":"Santos","year":"2017","journal-title":"Nat Rev Drug Discov"},{"issue":"3","key":"10.1016\/j.biopsych.2026.10.004_bib8","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/s41576-025-00904-4","article-title":"Genomics of drug target prioritization for complex diseases","volume":"27","author":"Chen","year":"2026","journal-title":"Nat Rev Genet"},{"issue":"213","key":"10.1016\/j.biopsych.2026.10.004_bib9","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/978-3-642-25758-2_14","article-title":"Development of disease-modifying treatment of schizophrenia","author":"Bespalov","year":"2012","journal-title":"Handb Exp Pharmacol"},{"issue":"4","key":"10.1016\/j.biopsych.2026.10.004_bib10","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1093\/schbul\/sbu170","article-title":"Treatments of Negative Symptoms in Schizophrenia: Meta-Analysis of 168 Randomized Placebo-Controlled Trials","volume":"41","author":"Fusar-Poli","year":"2015","journal-title":"Schizophr Bull"},{"issue":"12","key":"10.1016\/j.biopsych.2026.10.004_bib11","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1056\/NEJMoa051688","article-title":"Effectiveness of antipsychotic drugs in patients with chronic schizophrenia","volume":"353","author":"Lieberman","year":"2005","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.biopsych.2026.10.004_bib12","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/sj.mp.4001556","article-title":"Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs","volume":"10","author":"Miyamoto","year":"2005","journal-title":"Mol Psychiatry"},{"issue":"9","key":"10.1016\/j.biopsych.2026.10.004_bib13","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/s41583-024-00837-7","article-title":"Schizophrenia genomics: genetic complexity and functional insights","volume":"25","author":"Sullivan","year":"2024","journal-title":"Nat Rev Neurosci"},{"issue":"9","key":"10.1016\/j.biopsych.2026.10.004_bib14","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1038\/s41591-021-01475-7","article-title":"Prognostic value of polygenic risk scores for adults with psychosis","volume":"27","author":"Landi","year":"2021","journal-title":"Nat Med"},{"issue":"5","key":"10.1016\/j.biopsych.2026.10.004_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0019166","article-title":"Genetic background of patients from a university medical center in Manhattan: implications for personalized medicine","volume":"6","author":"Tayo","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.biopsych.2026.10.004_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.scr.2025.103662","article-title":"Generation of induced pluripotent stem cell line ISMMSi060-A from a patient with combined oxidative phosphorylation deficiency 25","volume":"83","author":"Salemi","year":"2025","journal-title":"Stem Cell Res"},{"issue":"5","key":"10.1016\/j.biopsych.2026.10.004_bib17","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.neuron.2013.05.029","article-title":"Rapid single-step induction of functional neurons from human pluripotent stem cells","volume":"78","author":"Zhang","year":"2013","journal-title":"Neuron"},{"key":"10.1016\/j.biopsych.2026.10.004_bib18","doi-asserted-by":"crossref","DOI":"10.1038\/s41563-024-02114-5","article-title":"Blood-brain-barrier-crossing lipid nanoparticles for mRNA delivery to the central nervous system","author":"Wang","year":"2025","journal-title":"Nat Mater"},{"issue":"40","key":"10.1016\/j.biopsych.2026.10.004_bib19","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202004452","article-title":"Leveraging mRNA Sequences and Nanoparticles to Deliver SARS-CoV-2 Antigens In Vivo","volume":"32","author":"Zeng","year":"2020","journal-title":"Adv Mater"},{"issue":"8","key":"10.1016\/j.biopsych.2026.10.004_bib20","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.biopsych.2005.08.029","article-title":"A pharmacological model for psychosis based on N-methyl-D-aspartate receptor hypofunction: molecular, cellular, functional and behavioral abnormalities","volume":"59","author":"Rujescu","year":"2006","journal-title":"Biol Psychiatry"},{"issue":"3","key":"10.1016\/j.biopsych.2026.10.004_bib21","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/s41588-023-01305-1","article-title":"Schizophrenia risk conferred by rare protein-truncating variants is conserved across diverse human populations","volume":"55","author":"Liu","year":"2023","journal-title":"Nat Genet"},{"issue":"7906","key":"10.1016\/j.biopsych.2026.10.004_bib22","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/s41586-022-04556-w","article-title":"Rare coding variants in ten genes confer substantial risk for schizophrenia","volume":"604","author":"Singh","year":"2022","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.biopsych.2026.10.004_bib23","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.neuron.2011.09.036","article-title":"Compartmentalized versus global synaptic plasticity on dendrites controlled by experience","volume":"72","author":"Makino","year":"2011","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.biopsych.2026.10.004_bib24","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a005736","article-title":"Homeostatic synaptic plasticity: local and global mechanisms for stabilizing neuronal function","volume":"4","author":"Turrigiano","year":"2012","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"2","key":"10.1016\/j.biopsych.2026.10.004_bib25","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.neuron.2018.10.018","article-title":"The AMPA Receptor Code of Synaptic Plasticity","volume":"100","author":"Diering","year":"2018","journal-title":"Neuron"},{"key":"10.1016\/j.biopsych.2026.10.004_bib26","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1146\/annurev.neuro.25.112701.142758","article-title":"AMPA receptor trafficking and synaptic plasticity","volume":"25","author":"Malinow","year":"2002","journal-title":"Annu Rev Neurosci"},{"key":"10.1016\/j.biopsych.2026.10.004_bib27","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1146\/annurev.ne.17.030194.000335","article-title":"Cloned glutamate receptors","volume":"17","author":"Hollmann","year":"1994","journal-title":"Annu Rev Neurosci"},{"issue":"1","key":"10.1016\/j.biopsych.2026.10.004_bib28","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.neuron.2014.08.044","article-title":"Regional diversity and developmental dynamics of the AMPA-receptor proteome in the mammalian brain","volume":"84","author":"Schwenk","year":"2014","journal-title":"Neuron"},{"issue":"2","key":"10.1016\/j.biopsych.2026.10.004_bib29","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0896-6273(03)00640-8","article-title":"AMPA receptor trafficking at excitatory synapses","volume":"40","author":"Bredt","year":"2003","journal-title":"Neuron"},{"issue":"3","key":"10.1016\/j.biopsych.2026.10.004_bib30","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0092-8674(01)00321-X","article-title":"Subunit-specific rules governing AMPA receptor trafficking to synapses in hippocampal pyramidal neurons","volume":"105","author":"Shi","year":"2001","journal-title":"Cell"},{"issue":"8080","key":"10.1016\/j.biopsych.2026.10.004_bib31","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/s41586-025-09289-0","article-title":"Gating and noelin clustering of native Ca(2+)-permeable AMPA receptors","volume":"645","author":"Fang","year":"2025","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.biopsych.2026.10.004_bib32","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1002\/ajmg.a.32858","article-title":"Aberrant GRIA3 transcripts with multi-exon duplications in a family with X-linked mental retardation","volume":"149A","author":"Bonnet","year":"2009","journal-title":"Am J Med Genet A"},{"issue":"3","key":"10.1016\/j.biopsych.2026.10.004_bib33","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1006\/geno.1999.6032","article-title":"Characterization of the human glutamate receptor subunit 3 gene (GRIA3), a candidate for bipolar disorder and nonspecific X-linked mental retardation","volume":"62","author":"Gecz","year":"1999","journal-title":"Genomics"},{"issue":"46","key":"10.1016\/j.biopsych.2026.10.004_bib34","doi-asserted-by":"crossref","first-page":"18163","DOI":"10.1073\/pnas.0708699104","article-title":"Mutations in ionotropic AMPA receptor 3 alter channel properties and are associated with moderate cognitive impairment in humans","volume":"104","author":"Wu","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"13","key":"10.1016\/j.biopsych.2026.10.004_bib35","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1002\/ajmg.a.31798","article-title":"Partial tandem duplication of GRIA3 in a male with mental retardation","volume":"143A","author":"Chiyonobu","year":"2007","journal-title":"Am J Med Genet A"},{"issue":"6","key":"10.1016\/j.biopsych.2026.10.004_bib36","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1002\/ajmg.a.35307","article-title":"Xq25 duplications encompassing GRIA3 and STAG2 genes in two families convey recognizable X-linked intellectual disability with distinctive facial appearance","volume":"161A","author":"Philippe","year":"2013","journal-title":"Am J Med Genet A"},{"issue":"7","key":"10.1016\/j.biopsych.2026.10.004_bib37","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1002\/mds.28058","article-title":"The GRIA3 c.2477G > A Variant Causes an Exaggerated Startle Reflex, Chorea, and Multifocal Myoclonus","volume":"35","author":"Piard","year":"2020","journal-title":"Mov Disord"},{"issue":"1","key":"10.1016\/j.biopsych.2026.10.004_bib38","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/s41439-023-00232-1","article-title":"GRIA3 p.Met661Thr variant in a female with developmental epileptic encephalopathy","volume":"10","author":"Okano","year":"2023","journal-title":"Hum Genome Var"},{"issue":"3","key":"10.1016\/j.biopsych.2026.10.004_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmg.2022.104442","article-title":"The p.Glu787Lys variant in the GRIA3 gene causes developmental and epileptic encephalopathy mimicking structural epilepsy in a female patient","volume":"65","author":"Martinez-Esteve Melnikova","year":"2022","journal-title":"Eur J Med Genet"},{"key":"10.1016\/j.biopsych.2026.10.004_bib40","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.eplepsyres.2018.05.004","article-title":"Retrospective genotype-phenotype analysis in a 305 patient cohort referred for testing of a targeted epilepsy panel","volume":"144","author":"Hesse","year":"2018","journal-title":"Epilepsy Res"},{"issue":"6","key":"10.1016\/j.biopsych.2026.10.004_bib41","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1161\/CIRCRESAHA.114.301621","article-title":"PCSK9: a key modulator of cardiovascular health","volume":"114","author":"Seidah","year":"2014","journal-title":"Circ Res"},{"issue":"1-2","key":"10.1016\/j.biopsych.2026.10.004_bib42","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ymgme.2020.08.008","article-title":"A new homozygous HERC1 gain-of-function variant in MDFPMR syndrome leads to mTORC1 hyperactivation and reduced autophagy during cell catabolism","volume":"131","author":"Schwarz","year":"2020","journal-title":"Mol Genet Metab"},{"issue":"1","key":"10.1016\/j.biopsych.2026.10.004_bib43","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1353\/ppp.2011.0005","article-title":"The dopamine hypothesis of schizophrenia: An historical and philosophical analysis","volume":"18","author":"Kendler","year":"2011","journal-title":"Philosophy, Psychiatry, & Psychology"},{"issue":"12","key":"10.1016\/j.biopsych.2026.10.004_bib44","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1016\/j.bbamcr.2013.07.002","article-title":"Specificity protein 4 functionally regulates the transcription of NMDA receptor subunits GluN1, GluN2A, and GluN2B","volume":"1833","author":"Priya","year":"2013","journal-title":"Biochim Biophys Acta"},{"issue":"17","key":"10.1016\/j.biopsych.2026.10.004_bib45","doi-asserted-by":"crossref","first-page":"5866","DOI":"10.1523\/JNEUROSCI.0167-10.2010","article-title":"Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis","volume":"30","author":"Hughes","year":"2010","journal-title":"J Neurosci"},{"issue":"5","key":"10.1016\/j.biopsych.2026.10.004_bib46","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1093\/schbul\/sbs076","article-title":"NMDA receptor and schizophrenia: a brief history","volume":"38","author":"Coyle","year":"2012","journal-title":"Schizophr Bull"},{"issue":"7906","key":"10.1016\/j.biopsych.2026.10.004_bib47","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/s41586-022-04434-5","article-title":"Mapping genomic loci implicates genes and synaptic biology in schizophrenia","volume":"604","author":"Trubetskoy","year":"2022","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.biopsych.2026.10.004_bib48","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/s41398-022-02253-w","article-title":"Glutamatergic dysfunction in Schizophrenia","volume":"12","author":"Kruse","year":"2022","journal-title":"Transl Psychiatry"},{"issue":"9","key":"10.1016\/j.biopsych.2026.10.004_bib49","doi-asserted-by":"crossref","first-page":"3583","DOI":"10.1038\/s41380-022-01649-w","article-title":"Relevance of interactions between dopamine and glutamate neurotransmission in schizophrenia","volume":"27","author":"Buck","year":"2022","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.biopsych.2026.10.004_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2021.105539","article-title":"GluA3-containing AMPA receptors: From physiology to synaptic dysfunction in brain disorders","volume":"161","author":"Italia","year":"2021","journal-title":"Neurobiology of Disease"},{"issue":"9","key":"10.1016\/j.biopsych.2026.10.004_bib51","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/nrd892","article-title":"The druggable genome","volume":"1","author":"Hopkins","year":"2002","journal-title":"Nat Rev Drug Discov"},{"issue":"6","key":"10.1016\/j.biopsych.2026.10.004_bib52","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/s41565-021-00898-0","article-title":"The current landscape of nucleic acid therapeutics","volume":"16","author":"Kulkarni","year":"2021","journal-title":"Nat Nanotechnol"},{"issue":"5","key":"10.1016\/j.biopsych.2026.10.004_bib53","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41576-021-00439-4","article-title":"Drug delivery systems for RNA therapeutics","volume":"23","author":"Paunovska","year":"2022","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.biopsych.2026.10.004_bib54","doi-asserted-by":"crossref","DOI":"10.1038\/s43586-022-00104-y","article-title":"Nanodelivery of nucleic acids","volume":"2","author":"Mendes","year":"2022","journal-title":"Nat Rev Methods Primers"},{"issue":"2","key":"10.1016\/j.biopsych.2026.10.004_bib55","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s13311-019-00736-1","article-title":"Nucleic Acid Therapeutics for Neurological Diseases","volume":"16","author":"Watts","year":"2019","journal-title":"Neurotherapeutics"},{"issue":"1","key":"10.1016\/j.biopsych.2026.10.004_bib56","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1080\/15476286.2021.2021650","article-title":"RNA-based therapeutics for neurological diseases","volume":"19","author":"Anthony","year":"2022","journal-title":"RNA Biol"},{"key":"10.1016\/j.biopsych.2026.10.004_bib57","unstructured":"WHO. WHO COVID-19 dashboard 2025 [Available from: https:\/\/data.who.int\/dashboards\/covid19\/vaccines."},{"issue":"3","key":"10.1016\/j.biopsych.2026.10.004_bib58","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1124\/pr.109.002451","article-title":"Glutamate receptor ion channels: structure, regulation, and function","volume":"62","author":"Traynelis","year":"2010","journal-title":"Pharmacol Rev"},{"issue":"6","key":"10.1016\/j.biopsych.2026.10.004_bib59","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1093\/bioinformatics\/btt607","article-title":"Protter: interactive protein feature visualization and integration with experimental proteomic data","volume":"30","author":"Omasits","year":"2014","journal-title":"Bioinformatics"}],"container-title":["Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322326015891?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322326015891?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:19:16Z","timestamp":1791919156000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006322326015891"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":59,"alternative-id":["S0006322326015891"],"URL":"https:\/\/doi.org\/10.1016\/j.biopsych.2026.10.004","relation":{},"ISSN":["0006-3223"],"issn-type":[{"value":"0006-3223","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of a messenger RNA therapy for schizophrenia","name":"articletitle","label":"Article Title"},{"value":"Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopsych.2026.10.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc on behalf of Society of Biological Psychiatry.","name":"copyright","label":"Copyright"}]}}